Pharma Journalist 8791 posts 0 comments

19th Pharmacovigilance 2019 will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry.  The…
Read More...

Semma Therapeutics, Inc., a biotechnology company pioneering the curative use of stem cells in regenerative medicine, announced the achievement of pre-clinical proof-of-concept based on…
Read More...

Lonza announced its entry into a binding contractual commitment for the purchase of a sterile drug product fill & finish facility from Novartis. The closing is expected to take…
Read More...

PTC Therapeutics, Inc. and Odylia Therapeutics announced a strategic collaboration to develop novel gene therapies in rare inherited retinal diseases (IRDs) utilizing the Anc80 vector…
Read More...

Boehringer Ingelheim and Yuhan Corporation announced a collaboration and license agreement for the development of a first-in-class dual agonist for the treatment of NASH and related…
Read More...

Pfizer Inc. announced the successful completion of its acquisition of the privately held clinical-stage biotechnology company Therachon Holding AG. Under the terms of the transaction,…
Read More...

Real World Evidence is at the root of an ongoing and critical transformation in medical care. By incorporating data from the real-world into their development programs, drug developers…
Read More...

PeptiDream Inc., a public Kanagawa-based biopharmaceutical company announced a new Peptide Drug Conjugate “PDC” collaboration agreement with Swiss-based Novartis. Under the agreement,…
Read More...

Aucta Pharmaceuticals announced that the Company has entered into an agreement with Eton Pharmaceuticals, Inc. to License U.S. marketing rights for AUC025. AUC025 is an innovative…
Read More...

ContraVir Pharmaceuticals, a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis…
Read More...